Predictors of Response to Chronic Hepatitis C Treatment

Ezequiel Ridruejo


Future Virology. 2012;7(11):1089-1101. 

In This Article

Future Perspective

New generations of direct antiviral therapies are in the pipeline for several companies. Even IFN-free regimes could be a possibility in the near future, perhaps in 3–6 years. These new drugs will change the HCV therapeutic scenario, as well as the predictors of response. We will see in the future how these treatments work, and how we can predict which treatment is the best option for which patient. There is no doubt that HCV treatment will become 'personalized', and there is hope for finding suitable predictors of response for each drug for a given patient.